Up to 50% of early RA patients are negative for the standard serological markers rheumatoid factor (RF) or anti-citrullinated protein antibodies (ACPA) including anti-cyclic citrullinated peptide (CCP). Here, PRTN3 is linked to rheumatoid arthritis.